Investigating the Impact of Patient-Related Factors on Speech Outcomes at 5 Years of Age in Children With a Cleft Palate.


Journal

The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association
ISSN: 1545-1569
Titre abrégé: Cleft Palate Craniofac J
Pays: United States
ID NLM: 9102566

Informations de publication

Date de publication:
12 2023
Historique:
medline: 23 10 2023
pubmed: 24 6 2022
entrez: 23 6 2022
Statut: ppublish

Résumé

To investigate the relationship between patient-related factors (sex, cleft type, cleft extent, and Robin Sequence [RS]) and speech outcome at 5 years of age for children born with a cleft palate ±  lip (CP ± L). 3157 Children (1426 female:1731 male) with a nonsyndromic CP ± L, born between 2006 and 2014 in England, Wales, and Northern Ireland. Perceptual speech analysis utilized the Cleft Audit Protocol for Speech-Augmented (CAPS-A) rating and UK National Speech Outcome Standards: Speech Standard 1 (SS1)-speech within the normal range, SS2a-no structurally related speech difficulties or history of speech surgery, and SS3-speech without significant cleft-related articulation difficulties. Odds of achieving SS1 were lower among boys (aOR 0.771 [CI 0.660-0.901]), those with clefts involving the lip and palate (vs palate only) (UCLP-aOR 0.719 [CI 0.591-0.875]; BCLP-aOR 0.360 [CI 0.279-0.463]), and clefts involving the hard palate (incomplete-aOR 0.701 [CI 0.540-0.909]; complete-aOR 0.393 [CI 0.308-0.501]). Similar relationships with these patient factors were observed for SS3. SS2 was affected by the extent of hard palate involvement (complete; aOR 0.449 [CI 0.348-0.580]). Although those with CP and RS were less likely to meet all 3 standards than those without RS, odds ratios were not significant when adjusting for sex and cleft extent. Sex, cleft type, and extent of hard palate involvement have a significant impact on speech outcome at 5 years of age. Incorporating these factors into risk-adjustment models for service-level outcome reporting is recommended.

Identifiants

pubmed: 35733360
doi: 10.1177/10556656221110094
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1578-1590

Déclaration de conflit d'intérêts

Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Sophie Butterworth (S)

Cleft Registry and Audit Network, Clinical Excellence Unit, The Royal College of Surgeons of England, London, UK.

Kate J Fitzsimons (KJ)

Cleft Registry and Audit Network, Clinical Excellence Unit, The Royal College of Surgeons of England, London, UK.

Jibby Medina (J)

Cleft Registry and Audit Network, Clinical Excellence Unit, The Royal College of Surgeons of England, London, UK.

Lorraine Britton (L)

Trent Regional Cleft Network, Nottingham University Hospital NHS Trust, Nottingham, UK.

Stephanie Van Eeden (S)

Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Hussain Wahedally (H)

London School of Hygiene and Tropical Medicine, London, UK.

Min Hae Park (MH)

London School of Hygiene and Tropical Medicine, London, UK.

Jan van Der Muelen (J)

Cleft Registry and Audit Network, Clinical Excellence Unit, The Royal College of Surgeons of England, London, UK.

Craig J H Russell (CJH)

Royal Hospital for Children, Queen Elisabeth University Hospital, Glasgow, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH